MarketPulse
L

$LSBCF

2 articles found
0 positive
2 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··The Schall Law Firm

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.
LSBCFsecurities fraudinvestor losses
BenzingaBenzinga··Prnewswire

LakeShore Biopharma Gets Revised Takeover Bid at Half Premium Amid Legal Setback

LakeShore Biopharma's special committee received a revised acquisition proposal at $0.06 per share, a 50% premium, after arbitral awards of RMB576.5 million against Chinese subsidiaries.
LSBCFacquisitionbiopharmaceutical